Skip to Main Content

Paper Details

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Blood
37
2021
Author NameAffiliation
Laura Z RassentiMoores Cancer Center, University of California San Diego
Thomas J KippsMoores Cancer Center, University of California San Diego
  • 1 - 2

Datasets

Release 1.2